Global cell sorting market was worth USD 405.47 Million in 2018. It is projected to grow at a compound annual rate (CAGR of 10.5%) between 2019 and 2026. Growth is expected to be driven by research and technological advances in cell sorting technology, as well as rising pharmaceutical & biological companies.
The market has seen significant growth due to the increasing R&D investments made by biotechnology and pharmaceutical companies. Research activities using cell sorting will increase due to new therapeutics being developed. The growth of biotech and pharma companies is also influenced by the increasing prevalence of diseases and the aging population.
Researchers in biology laboratories have used flow cytometry-based sorting extensively for cell isolation. This field has seen significant technological advances. In August 2018, researchers published in Cell the invention of Image-Activated Cell Sorting. The instrument combines microfluidic and optical technologies with electrical and mechanical technology to sort cells based on their global phenotypic profiles as well as their morphological and spatial properties. It is image-driven. This technique allows you to view cell images in 2D. It works by stacking 1D spatial profiles, after demodulating detected transmission and fluorescence signal.
Microfluidic technology is becoming more popular because it's easy and quick to use and has lower costs than other methods like FACS or MACS. Instruments with microfluidic technology can speed up cell sorting by separating billions of cells per second, thanks to its non-magnetic cell sorting technique.
The market is also being driven by the growing prevalence of HIV/cancer. Flow cytometry-based tests help to identify and quantify infected cells from HIV patients. Cell sorting has been combined with molecular biology techniques and protomics to characterize metastatic and primary cancer cell populations as well as single tumor cells.
There are three segments to the market: cell sorters, services and reagents, consumables, and consumables. The market was dominated by cell sorters in 2018 due to their superior technology. New instruments have made it easier to sort and result in faster results. These machines are extremely expensive and cost around USD 150,000. This can be attributed partly to the high market share of this segment.
Due to their wide range of applications, consumables and reagents also accounted for a large share in 2018. Cell labeling reagents are now widely available due to the increasing use of sorting technology. Due to the large number of cell-based research institutes in academia, the services segment will see significant growth.
Fluorescence-based Droplet Cell Sorting segment (FACS), which is highly precise and accurate, was the most profitable technology segment in 2018. The machines that are based on this technology are very costly and require skilled workers to operate. This can slow down the growth of this technology compared to magnetic-activated cells sorting.
The segment of Microfluidics is expected to have a high CAGR during the forecast period. This is due to its higher output. It allows for 99% cell purity with a cell output of 48,000/s. This technology is being used to develop new products. Microfluidic-based instruments also tend to be less expensive than FACS which is driving segment growth.
Research applications held the largest market share among all application segments in 2018. Research applications held the largest market share in 2018. This is due to growing interest in cell analysis, stem cells, drug discovery and cell engineering . Because it can analyze heterogeneous cells, flow cytometry-based sorting is a key component in the development and implementation of therapeutic products.
Due to rising rates of cancer and HIV, clinical applications will experience a significant growth rate over the forecast period. Researchers have developed a new product that uses microfluidic technology to separate cancerous cells from patients' peripheral blood. Cell-by-Cell Morphological (MORE), which allows for the identification of major blood cells and their pathological changes in disease in vitro and in vivo, is a useful tool.
Research institutions held the largest share in cell sorting market 2018 on the basis of end use, due to an increasing number of research activities in cell analysis. Segment growth is also being driven by the increase in cell-based therapies. Stem cell research and cancer research are both gaining popularity.
The forecast period will see a significant increase in the CAGR for academic and medical schools. Research activities have grown due to increased collaborations between academic institutions, pharma and biotech companies. These academic institutions also offer outsourcing services for cell analysis, which allows companies to produce a rapid product.
Due to its high investment in the pharmaceutical and biotechnology industries, increasing use of this technique in cancer research and development of new therapeutics in the U.S., North America dominated 2018's market. Regional growth is also driven by the rising incidence of cancers in the U.S. A high demand has resulted from the development of sorting tools.
Due to the rising incidence of HIV and cancer, Asia Pacific is expected to experience lucrative growth during the forecast period. WHO statistics for 2018 show that Asia had 48.4% of the global cancer incidence. Regional growth will be boosted by the booming Indian pharmaceutical and biotechnology industries.
The key companies involved in strategic initiatives include regional expansion, product development and strategic collaborations & partnership. In 2018, Becton, Dickinson and Company launched its new BD FACSymphony® S6 cell sorter to improve cell population sorting and analyze cell phenotypes in multiomics and immunology research. The cell sorting market is dominated by the following players:
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Beckman Coulter, Inc.
Sony Biotechnology Inc.
Miltenyi Biotec GmbH
On-Chip Biotechnologies Co., Ltd.
Cytonome/St, LLC
Union Biometrica, Inc.
Thermo Fisher Scientific, Inc.
Up Market Research published a new report titled “Cell Sorting Market research report which is segmented by Application (Clinical, Research), by Product (Reagents & Consumables, Services, Cell Sorters), By Players/Companies Thermo Fisher Scientific Inc, Becton Dickinson and Company, Miltenyi Biotec GmbH, Beckman Coulter Inc, Bio-Rad Laboratories Inc, On-Chip Biotechnologies Co Ltd, Union Biometrica Inc, Cytonome/St LLC, Sony Biotechnology Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Cell Sorting Market Research Report |
By Application | Clinical, Research |
By Product | Reagents & Consumables, Services, Cell Sorters |
By Companies | Thermo Fisher Scientific Inc, Becton Dickinson and Company, Miltenyi Biotec GmbH, Beckman Coulter Inc, Bio-Rad Laboratories Inc, On-Chip Biotechnologies Co Ltd, Union Biometrica Inc, Cytonome/St LLC, Sony Biotechnology Inc |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 200 |
Number of Tables & Figures | 140 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Application (Clinical, Research), by Product (Reagents & Consumables, Services, Cell Sorters).
Cell Sorting Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Cell Sorting Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Cell Sorting Market Report:
Some other reports from this category!